The atypical antipsychotic (APs) drugs have become the most widely used agents to treat a variety of psychoses because of their superiority with regard to safety and tolerability profile compared to conventional/'typical' APs.
An update of safety of clinically used atypical antipsychotics / Orsolini, L., Tomasetti, C., Valchera, A., Vecchiotti, R., Matarazzo, I., Vellante, F., Iasevoli, F., Buonaguro, E.F., Fornaro, M., Fiengo, A.L.C., Martinotti, G., Mazza, M., Perna, G., Carano, A., DE BARTOLOMEIS, A., Di Giannantonio, M., De Berardis, D.. - In: EXPERT OPINION ON DRUG SAFETY. - ISSN 1474-0338. - 15:10(2016), pp. 1329-47-1347. [10.1080/14740338.2016.1201475]
An update of safety of clinically used atypical antipsychotics
TOMASETTI, CARMINE;IASEVOLI, FELICE;BUONAGURO, ELISABETTA FILOMENA;FORNARO, MICHELE;FIENGO, ANNASTASIA LUCIA CARMELA;DE BARTOLOMEIS, ANDREA;
2016
Abstract
The atypical antipsychotic (APs) drugs have become the most widely used agents to treat a variety of psychoses because of their superiority with regard to safety and tolerability profile compared to conventional/'typical' APs.| File | Dimensione | Formato | |
|---|---|---|---|
|
An update of safety of clinically used atypical antipsychotics.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
1.6 MB
Formato
Adobe PDF
|
1.6 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
